109 related articles for article (PubMed ID: 33183428)
21. Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells.
Kim GD; Oh J; Park HJ; Bae K; Lee SK
Int J Oncol; 2013 Aug; 43(2):600-10. PubMed ID: 23708970
[TBL] [Abstract][Full Text] [Related]
22. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
[TBL] [Abstract][Full Text] [Related]
23. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
[TBL] [Abstract][Full Text] [Related]
24. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
[TBL] [Abstract][Full Text] [Related]
25. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
26. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
[TBL] [Abstract][Full Text] [Related]
27. P27/Kip1 is responsible for magnolol-induced U373 apoptosis in vitro and in vivo.
Chen LC; Lee WS
J Agric Food Chem; 2013 Mar; 61(11):2811-9. PubMed ID: 23448150
[TBL] [Abstract][Full Text] [Related]
28. Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals.
Liu SH; Shen CC; Yi YC; Tsai JJ; Wang CC; Chueh JT; Lin KL; Lee TC; Pan HC; Sheu ML
Br J Pharmacol; 2010 Aug; 160(8):1963-72. PubMed ID: 20649594
[TBL] [Abstract][Full Text] [Related]
29. Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis.
Lin SY; Liu JD; Chang HC; Yeh SD; Lin CH; Lee WS
J Cell Biochem; 2002; 84(3):532-44. PubMed ID: 11813258
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
31. Effects of magnolol and honokiol derived from traditional Chinese herbal remedies on gastrointestinal movement.
Zhang WW; Li Y; Wang XQ; Tian F; Cao H; Wang MW; Sun QS
World J Gastroenterol; 2005 Jul; 11(28):4414-8. PubMed ID: 16038044
[TBL] [Abstract][Full Text] [Related]
32. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
[TBL] [Abstract][Full Text] [Related]
33. Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review.
Mottaghi S; Abbaszadeh H
Nutr Cancer; 2022; 74(3):761-778. PubMed ID: 34047218
[TBL] [Abstract][Full Text] [Related]
34. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms for the magnolol-induced cell death of CGTH W-2 thyroid carcinoma cells.
Huang SH; Chen Y; Tung PY; Wu JC; Chen KH; Wu JM; Wang SM
J Cell Biochem; 2007 Jul; 101(4):1011-22. PubMed ID: 17390340
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
37. Honokiol reduces oxidative stress, c-jun-NH2-terminal kinase phosphorylation and protects against glycochenodeoxycholic acid-induced apoptosis in primary cultured rat hepatocytes.
Park EJ; Kim SY; Zhao YZ; Sohn DH
Planta Med; 2006 Jun; 72(7):661-4. PubMed ID: 16732532
[TBL] [Abstract][Full Text] [Related]
38. Magnolol and honokiol exert a synergistic anti-tumor effect through autophagy and apoptosis in human glioblastomas.
Cheng YC; Hueng DY; Huang HY; Chen JY; Chen Y
Oncotarget; 2016 May; 7(20):29116-30. PubMed ID: 27074557
[TBL] [Abstract][Full Text] [Related]
39. Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway.
Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Ko YB
Int J Mol Med; 2019 May; 43(5):1969-1978. PubMed ID: 30864681
[TBL] [Abstract][Full Text] [Related]
40. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
